CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME
This 12-week study included 60 patients (age 45-65 years) with metabolic syndrome (MS), chronic heart failure (CHF) of II-III functional class (FC), and recent myocardial infarction. The participants were randomised into two groups (n=30 for each). In the main group, standard CHF therapy was combine...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2010-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849688692607680512 |
|---|---|
| author | M. E. Statsenko S. V. Turkina E. D. Evtereva O. E. Sporova S. V. Fabritskaya |
| author_facet | M. E. Statsenko S. V. Turkina E. D. Evtereva O. E. Sporova S. V. Fabritskaya |
| author_sort | M. E. Statsenko |
| collection | DOAJ |
| description | This 12-week study included 60 patients (age 45-65 years) with metabolic syndrome (MS), chronic heart failure (CHF) of II-III functional class (FC), and recent myocardial infarction. The participants were randomised into two groups (n=30 for each). In the main group, standard CHF therapy was combined with Cardionate 1,0 g/d (meldonium, Makiz-Pharma, Russia). Cytoprotector Cardionate, as a part of complex CHF therapy in MS patients, improved CHF FC and exercise capacity, increased left ventricular (LV) ejection fraction, normalised LV myocardial structure and function, and improved renal function, also reducing insulin resistance severity and improving lipid and carbohydrate metabolism. |
| format | Article |
| id | doaj-art-ec5ca5ce90954b0f9c13392f42155d2a |
| institution | DOAJ |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2010-08-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-ec5ca5ce90954b0f9c13392f42155d2a2025-08-20T03:21:54Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202010-08-010435391253CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROMEM. E. Statsenko0S. V. Turkina1E. D. Evtereva2O. E. Sporova3S. V. Fabritskaya4Волгоградский государственный медицинский университет, ВолгоградВолгоградский государственный медицинский университет, ВолгоградВолгоградский государственный медицинский университет, ВолгоградГородская клиническая больница № 3, ВолгоградГородская клиническая больница № 3, ВолгоградThis 12-week study included 60 patients (age 45-65 years) with metabolic syndrome (MS), chronic heart failure (CHF) of II-III functional class (FC), and recent myocardial infarction. The participants were randomised into two groups (n=30 for each). In the main group, standard CHF therapy was combined with Cardionate 1,0 g/d (meldonium, Makiz-Pharma, Russia). Cytoprotector Cardionate, as a part of complex CHF therapy in MS patients, improved CHF FC and exercise capacity, increased left ventricular (LV) ejection fraction, normalised LV myocardial structure and function, and improved renal function, also reducing insulin resistance severity and improving lipid and carbohydrate metabolism.https://russjcardiol.elpub.ru/jour/article/view/1466metabolic syndromechronic heart failurecardionateinsulin resistancecarbohydrate and lipid metabolism |
| spellingShingle | M. E. Statsenko S. V. Turkina E. D. Evtereva O. E. Sporova S. V. Fabritskaya CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME Российский кардиологический журнал metabolic syndrome chronic heart failure cardionate insulin resistance carbohydrate and lipid metabolism |
| title | CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME |
| title_full | CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME |
| title_fullStr | CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME |
| title_full_unstemmed | CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME |
| title_short | CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME |
| title_sort | cardionate in combined therapy of ischemic chronic heart failure among patients with metabolic syndrome |
| topic | metabolic syndrome chronic heart failure cardionate insulin resistance carbohydrate and lipid metabolism |
| url | https://russjcardiol.elpub.ru/jour/article/view/1466 |
| work_keys_str_mv | AT mestatsenko cardionateincombinedtherapyofischemicchronicheartfailureamongpatientswithmetabolicsyndrome AT svturkina cardionateincombinedtherapyofischemicchronicheartfailureamongpatientswithmetabolicsyndrome AT edevtereva cardionateincombinedtherapyofischemicchronicheartfailureamongpatientswithmetabolicsyndrome AT oesporova cardionateincombinedtherapyofischemicchronicheartfailureamongpatientswithmetabolicsyndrome AT svfabritskaya cardionateincombinedtherapyofischemicchronicheartfailureamongpatientswithmetabolicsyndrome |